T cell lymphoblastic lymphoma with uncommon CD20 expression

被引:1
|
作者
Diez-Feijoo, Ramon [1 ]
Rodriguez-Sevilla, Juan Jose [1 ]
Salido, Marta [1 ]
Colomo, Luis [1 ]
Salar, Antonio [1 ]
机构
[1] Hosp Mar, Dept Hematol, Passeig Maritim 25, Barcelona 08003, Spain
关键词
CD20; CDKN2A; NOTCH2; T lymphoblastic lymphoma;
D O I
10.1111/ijlh.13769
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report an interesting case of a T lymphoblastic lymphoma (T-LBL) with uncommon CD20 expression. Immunophenotype analysis showed TdT expression with positivity of CD3 and CD7 among other T-lineage markers. Other non-T markers such as CD79a or myeloid-associated antigens were negative. Molecular studies were performed evidencing clonal rearrangements for gamma and beta chain T cell receptor were clonal in the lymph node biopsy. Cytogenetic analysis showed deletions in CDKN2A and NOTCH2 genes. CD20 when present in T-LBL can lead to a false diagnosis of B-LBL. In this scenario, analysis of rearrangements of both immunoglobulin heavy chain B cell receptor and rearrangement of the T cell receptor can be very helpful.
引用
收藏
页码:234 / 235
页数:2
相关论文
共 50 条
  • [41] Pitfalls in diagnosing a case of extranodal NK/T-cell lymphoma with CD20 aberrant expression and IGH gene rearrangement
    Liu, Chenxi
    Li, Fan
    Mao, Chunyan
    Dangzeng, Zhuoma
    Wang, Lin
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2023, 50 (12) : 1052 - 1058
  • [42] 5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: A case report
    Tsutsumi Y.
    Ohigashi H.
    Ito S.
    Shiratori S.
    Teshima T.
    [J]. Journal of Medical Case Reports, 10 (1)
  • [43] Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression
    Davis, TA
    Czerwinski, DK
    Levy, R
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (03) : 611 - 615
  • [44] CD5-positive diffuse large B-cell lymphoma with an unusual phenotype: Cytoplasmic CD20(+), surface CD20(-)
    Yokose, Norio
    Shioi, Yumiko
    Sugisaki, Yuich
    Ohaki, Yoshiharu
    Ogata, Kiyoyuki
    Dan, Kazuo
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1415 - 1417
  • [45] CD20 positive T-cell lymphoma/leukemia: A rare entity with potential diagnostic pitfalls
    Buckner, Carl L.
    Christiansen, Lydia R.
    Bourgeois, Danyel
    Lazarchick, John J.
    Lazarchick, John
    [J]. ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2007, 37 (03): : 263 - 267
  • [46] Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
    Johnson, Nathalie A.
    Boyle, Merrill
    Bashashati, Ali
    Leach, Stephen
    Brooks-Wilson, Angela
    Sehn, Laurie H.
    Chhanabhai, Mukesh
    Brinkman, Ryan R.
    Connors, Joseph M.
    Weng, Andrew P.
    Gascoyne, Randy D.
    [J]. BLOOD, 2009, 113 (16) : 3773 - 3780
  • [47] Prognostic significance of CD20 expression in pediatric and adolescent B-cell precursor acute lymphoblastic leukemia
    Pathak, Nivedita
    Sazawal, Sudha
    Mishra, Jyoti
    Mishra, Akhilesh
    Bakhshi, Sameer
    Raina, Vinod
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 : 17 - 17
  • [48] Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature
    Duman, Berna Bozkurt
    Sahin, Berksoy
    Ergin, Melek
    Guvenc, Birol
    [J]. MEDICAL ONCOLOGY, 2012, 29 (02) : 1223 - 1226
  • [49] Loss of CD20 antigen expression after rituximab therapy of CD20 positive B cell lymphoma (diffuse large B cell extranodal marginal zone lymphoma combination): A case report and review of the literature
    Berna Bozkurt Duman
    Berksoy Şahin
    Melek Ergin
    Birol Guvenc
    [J]. Medical Oncology, 2012, 29 : 1223 - 1226
  • [50] Primary central nervous system extranodal nasal-type natural killer/T-cell lymphoma with CD20 expression
    Li, Dujuan
    Fu, Fangfang
    Lian, Lifei
    [J]. NEUROPATHOLOGY, 2018, 38 (02) : 198 - 204